A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity
出版年份 2022 全文链接
标题
A tumor metastasis‐associated molecule
TWIST1
is a favorable target for cancer immunotherapy due to its immunogenicity
作者
关键词
-
出版物
CANCER SCIENCE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-05-17
DOI
10.1111/cas.15429
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
- (2022) Erika Salvatori et al. npj Vaccines
- A stealth antigen SPESP1, which is an epigenetically silenced in tumors, is a suitable target for cancer immunotherapy
- (2021) Akemi Kosaka et al. CANCER SCIENCE
- CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
- (2021) Akemi Kosaka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer
- (2020) Mizuho Ohara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma
- (2020) Ryusuke Hayashi et al. OncoImmunology
- An evolutionarily conserved DNA architecture determines target specificity of the TWIST family bHLH transcription factors
- (2015) Andrew T. Chang et al. GENES & DEVELOPMENT
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Twist1 correlates with poor differentiation and progression in gastric adenocarcinomaviaelevation of FGFR2 expression
- (2015) Dong-Yuan Zhu WORLD JOURNAL OF GASTROENTEROLOGY
- Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine
- (2014) Junya Ohtake et al. IMMUNOLOGY LETTERS
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
- (2013) Nienke van Rooij et al. JOURNAL OF CLINICAL ONCOLOGY
- Getting Personal with Neoantigen-Based Therapeutic Cancer Vaccines
- (2013) N. Hacohen et al. Cancer Immunology Research
- Twist Is a New Prognostic Marker for Renal Survival in Patients with Chronic Kidney Disease
- (2012) Shiren Sun et al. AMERICAN JOURNAL OF NEPHROLOGY
- Twist1 Is an Independent Prognostic Factor of Esophageal Squamous Cell Carcinoma and Associated with Its Epithelial–Mesenchymal Transition
- (2011) Keun-Woo Lee et al. ANNALS OF SURGICAL ONCOLOGY
- MAGE-A3 and MAGE-A4 specific CD4+ T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes
- (2010) Valérie Cesson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Identification of novel helper epitopes of MAGE-A4 tumour antigen: useful tool for the propagation of Th1 cells
- (2009) T Ohkuri et al. BRITISH JOURNAL OF CANCER
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma
- (2009) Ken Sasaki et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Prognostic significance of hypoxia-inducible factor-1 , TWIST1 and Snail expression in resectable non-small cell lung cancer
- (2009) J-J Hung et al. THORAX
- Effect and mechanism of the Twist gene on invasion and metastasis of gastric carcinoma cells
- (2008) Geng-Qiu Luo et al. WORLD JOURNAL OF GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started